This inventor holds 1 USPTO granted patent. Top assignee: Mitsui Chemicals, Inc.. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Tsutomu Sato: Innovator in Pharmaceutical Preparations
Introduction
Tsutomu Sato is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of human growth hormone preparations. His innovative work has led to advancements that benefit the medical community and patients alike.
Latest Patents
Tsutomu Sato holds a patent for a pharmaceutical preparation containing human growth hormone. This stable preparation involves a molecular weight of approximately 20,000 and includes a water-soluble heterocyclic compound, such as creatinine, along with a salt of acetyltryptophane and nicotinamide. This formulation is designed to prevent the insolubilization of human growth hormone in aqueous solutions, enhancing its effectiveness.
Career Highlights
Sato is associated with Mitsui Chemicals, Inc., where he applies his expertise in pharmaceutical development. His work has been instrumental in creating stable and effective pharmaceutical products that address various health issues.
Collaborations
Throughout his career, Tsutomu Sato has collaborated with esteemed colleagues, including Teruo Ito and Akira Fukuhara. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Tsutomu Sato's contributions to pharmaceutical preparations highlight his role as a key innovator in the field. His patent for a stable human growth hormone formulation exemplifies the impact of his work on medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile